Oncolytics Biotech (Canada)
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Oncolytics Biotech (Canada), Canada, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
50%
Total
Publications
245
Total Open
Publications
122
Total
Citations
7K
Open Access
Percentage
50%
Total
Publications
245
Total Open
Publications
122
Total
Citations
7K
Breakdown
Publisher Open
17%
Both
26%
Other Platform Open
7%
Closed
50%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 31%
32
Hybrid 37%
39
No Guarantees 32%
33
Other Platform Open
Domain 89%
72
Institution 23%
19
Public 14%
11
Other Internet 10%
8
Preprint 9%
7
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 71 |
Europe PMC | Domain | 42 |
DOI | Other Internet | 30 |
Figshare | Public | 13 |
whiterose.ac.uk OAI-PMH Repository | Institution | 11 |
Research Square | Preprint | 9 |
Semantic Scholar | Public | 6 |
University of Surrey - Surrey Open Research repository | Institution | 4 |
University College London - UCL Discovery | Institution | 4 |
University of Leeds, The University of Sheffield, University of York - White Rose Research Online | Institution | 3 |